Truist reiterates Hold on Immunovant stock after trial failure.
Share this article
Corporate
Score 35
Bearish
Truist reiterates Hold on Immunovant stock after trial failure
Apr 02, 2026 16:45 UTC
IMVT
Short term
Related Articles
Score 25
Form 6K Moolec Science SA For: 2 April
Apr 02, 18:50
Score 25
Form 6K British American Tobacco p.l.c. For: 2 April
Apr 02, 18:50
Score 55
Bullish
SBAC Communications Shares Surge on Takeover Speculation
Apr 02, 18:50
Score 35
OpenAI acquires technology talk show TBPN in surprise move
Apr 02, 18:48
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.